Lifescan May Be Misleading Customers About SureStep Recall, FDA Says

Purchasers of Lifescan's SureStep home glucose monitors may be "misled" by the firm's recall, which the Johnson & Johnson subsidiary "has characterized...as a product replacement program," FDA cautioned in a July 28 press release following up the company's June 4 Class I recall.

More from Archive

More from Medtech Insight